Gian Salzmann, MD, PhD (Zurich, Switzerland), reviews key literature highlighting the advantages of using autologous chondrocytes in the treatment of articular cartilage lesions.
This is the next video activity. After 10 seconds, your browser will automatically be directed to this unless you select Cancel.
OTIF: Single Stage, Matrix-Augmented Autologous Chondrocyte Transplantation
Length: 8:26